Assessment of KAN-101 in Celiac Disease (ACeD) Study Open
The ACeD Study is looking for volunteers with celiac disease to participate in a phase 1 clinical trial testing the investigational drug KAN-101.
Continue ReadingThe ACeD Study is looking for volunteers with celiac disease to participate in a phase 1 clinical trial testing the investigational drug KAN-101.
Continue ReadingWe are pleased to share that CEO Marilyn Geller will be presenting as the Patient Advocate at the March 18-19 National Institute of Allergy and Infectious Diseases Accelerating Progress in Celiac Disease Workshop. We encourage you to register to attend this seminal virtual meeting.
Continue ReadingThe Celiac Disease in Learning Environments: A Continuing Education Program for Nurses Who Care for Children with Celiac Disease training seminar will complement the recommendations found in the 2020 Voluntary Recommendations for Managing Celiac Disease in Learning Environments.
Continue ReadingRegistration is open for Virtual Camp Celiac 2021 for children ages 9-17 years old, diagnosed with celiac disease requiring a lifelong strict gluten-free diet.
Continue ReadingThe Celiac Disease Genomic Environmental Microbiome and Metabolomic (CDGEMM) study is revealing how genetic and lifestyle factors make children susceptible to autoimmune diseases such as celiac disease, inflammatory bowel disease, and multiple sclerosis.
Continue ReadingWith your help, we have invested significant resources into changing that reality in Washington, DC, and we are beginning to see a return on that investment.
Continue ReadingDr. Don Kasarda was a teacher, a mentor, and a treasured CDF Medical Advisory Board member since the early 1990s. A dedicated scientist for more than 50 years, he was a recognized expert in wheat gluten proteins and celiac disease.
Continue ReadingThank you to ImmunogenX for sponsoring our upcoming Patient Education and Advocacy Summit. ImmunogenX is a clinical stage biopharmaceutical company focused on developing therapeutic and diagnostic solutions for celiac disease. Registration closes soon so be sure to register today!
Continue ReadingThank you to Kanyos Bio, Inc., for sponsoring our upcoming Patient Education and Advocacy Summit. They are working to make a meaningful difference in the lives of patients suffering from autoimmune diseases by restoring normal immune tolerance. Register now!
Continue ReadingThis self-paced video series instructs schools and patient families in how to implement federal accommodations for celiac disease, based upon what is medically and psychologically necessary for children to succeed. We encourage you to share it with your schools.
Continue Reading